Literature DB >> 12717399

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

Nobukazu Yuki1, Takayuki Nagaoka, Masatoshi Yamashiro, Kiyoshi Mochizuki, Akira Kaneko, Keiji Yamamoto, Masao Omura, Kazumasa Hikiji, Michio Kato.   

Abstract

The long-term impact of acute self-limited hepatitis B on the liver is unknown. Fourteen patients were recalled at a median of 4.2 years (range, 1.8-9.5 years) after the onset of acute hepatitis B. All showed clinical and serologic recovery with circulating hepatitis B surface antigen (HBsAg) clearance. Antibody to HBsAg (anti-HBs) had developed in 12 patients. Nine underwent liver biopsies at a median of 7.2 years, and histologic findings were evaluated using Ishak scores. Serum samples and frozen liver tissue were subjected to real-time detection polymerase chain reaction (PCR) to quantify the surface and X regions of the hepatitis B virus (HBV) genome and qualitative PCR to detect the covalently closed circular (ccc) HBV DNA replicative intermediate. Three patients had low levels of circulating HBV DNA up to 8.9 years after the onset, whereas both HBV DNA surface and X regions were found in the liver of all 9 patients examined, including 7 negative for serum HBV DNA. Liver viral loads assessed by the 2 regions showed a significant correlation (r = 0.946; P =.008), and all patients tested positive for ccc HBV DNA. Liver fibrosis and mild inflammation persisted in 8 patients. The fibrosis stage had relation to peak serum HBV DNA in the acute phase (P =.046) but not to liver viral loads in the late convalescent phase. In conclusion, occult HBV infection persists in the liver and is accompanied by abnormal liver histology for a decade after complete clinical recovery from acute self-limited hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717399     DOI: 10.1053/jhep.2003.50171

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  43 in total

Review 1.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  [Current problems of hepatitis].

Authors:  H P Dienes; U Drebber
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 3.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

4.  Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Authors:  Ankur Varma; Laura Biritxinaga; Rima M Saliba; Maximilian Stich; Sarah Francesca Jauch; Aimaz Afrough; Medhavi Honhar; Uday R Popat; Mehnaz A Shafi; Nina Shah; Qaiser Bashir; Yvonne Dinh; Chitra Hosing; Richard E Champlin; Muzaffar H Qazilbash
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-04       Impact factor: 5.742

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

6.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

7.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

Review 8.  Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.

Authors:  Masaru Kato; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2015-11-16       Impact factor: 2.631

Review 9.  Role of occult hepatitis B virus infection in chronic hepatitis C.

Authors:  Nicola Coppola; Lorenzo Onorato; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Salvatore Martini; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy.

Authors:  Mohamed H Emara; Nahla E El-Gammal; Lamiaa A Mohamed; Maged M Bahgat
Journal:  Virol J       Date:  2010-11-17       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.